AAAAAA

   
Results: 1-21 |
Results: 21

Authors: MAJUMDAR SR ROSSDEGNAN D SOUMERAI SB
Citation: Sr. Majumdar et al., A COMPUTER-ASSISTED MANAGEMENT PROGRAM FOR ANTIINFECTIVE AGENTS, The New England journal of medicine, 338(24), 1998, pp. 1775-1775

Authors: BRUFSKY JW ROSSDEGNAN D CALABRESE D GAG XM SOUMERAI SB
Citation: Jw. Brufsky et al., SHIFTING PHYSICIAN PRESCRIBING TO A PREFERRED HISTAMINE-2-RECEPTOR ANTAGONIST - EFFECTS OF A MULTIFACTORIAL INTERVENTION IN A MIXED-MODEL HEALTH MAINTENANCE ORGANIZATION, Medical care, 36(3), 1998, pp. 321-332

Authors: SOUMERAI SB ROSSDEGNAN D FORTESS EE WALSER BL
Citation: Sb. Soumerai et al., DETERMINANTS OF CHANGE IN MEDICAID PHARMACEUTICAL COST-SHARING - DOESEVIDENCE AFFECT POLICY, The Milbank quarterly, 75(1), 1997, pp. 11

Authors: MADDEN JM QUICK JD ROSSDEGNAN D KAFLE KK
Citation: Jm. Madden et al., UNDERCOVER CARESEEKERS - SIMULATED CLIENTS IN THE STUDY OF HEALTH PROVIDER BEHAVIOR IN DEVELOPING-COUNTRIES, Social science & medicine, 45(10), 1997, pp. 1465-1482

Authors: SOUMERAI SB ROSSDEGNAN D
Citation: Sb. Soumerai et D. Rossdegnan, INSURANCE COPAYMENTS AND DELAYS IN SEEKING EMERGENCY CARE, The New England journal of medicine, 337(17), 1997, pp. 1247-1247

Authors: GOEL PK ROSSDEGNAN D MCLAUGHLIN TJ SOUMERAI SB
Citation: Pk. Goel et al., INFLUENCE OF LOCATION AND STAFF KNOWLEDGE ON QUALITY OF RETAIL PHARMACY PRESCRIBING FOR CHILDHOOD DIARRHEA IN KENYA, International journal for quality in health care, 8(6), 1996, pp. 519-526

Authors: WALSER BL ROSSDEGNAN D SOUMERAI SB
Citation: Bl. Walser et al., DO OPEN FORMULARIES INCREASE ACCESS TO CLINICALLY USEFUL DRUGS, Health affairs, 15(3), 1996, pp. 95-109

Authors: GOEL P ROSSDEGNAN D BERMAN P SOUMERAI S
Citation: P. Goel et al., RETAIL PHARMACIES IN DEVELOPING-COUNTRIES - A BEHAVIOR AND INTERVENTION FRAMEWORK, Social science & medicine, 42(8), 1996, pp. 1155-1161

Authors: ROSSDEGNAN D SOUMERAI SB GOEL PK BATES J MAKHULO J DONDI N",SUTOTO,"ADI D FERRAZTABOR L HOGAN R
Citation: D. Rossdegnan et al., THE IMPACT OF FACE-TO-FACE EDUCATIONAL OUTREACH ON DIARRHEA TREATMENTIN PHARMACIES, Health policy and planning, 11(3), 1996, pp. 308-318

Authors: ROSSDEGNAN D SOUMERAI SB
Citation: D. Rossdegnan et Sb. Soumerai, HMO FORMULARIES AND CARE COSTS, Lancet, 347(9010), 1996, pp. 1264-1264

Authors: WILSON MR MANSOUR M ATUD AE CASEY R FOBI G MOUKOURI E ALEMAYEHU W MARTONE JF ROSSDEGNAN D
Citation: Mr. Wilson et al., A POPULATION-BASED STUDY OF XEROPHTHALMIA IN THE EXTREME NORTH PROVINCE OF CAMEROON, WEST-AFRICA, Archives of ophthalmology, 114(4), 1996, pp. 464-468

Authors: ROSSDEGNAN D SOUMERAI SB AVORN J BOHN RL BRIGHT R ALEDORT LM
Citation: D. Rossdegnan et al., HEMOPHILIA HOME TREATMENT - ECONOMIC-ANALYSIS AND IMPLICATIONS FOR HEALTH-POLICY, International journal of technology assessment in health care, 11(2), 1995, pp. 327-344

Authors: SCHWAB L WHITFIELD R ROSSDEGNAN D STEINKULLER P SWARTWOOD J
Citation: L. Schwab et al., THE EPIDEMIOLOGY OF TRACHOMA IN RURAL KENYA - VARIATION IN PREVALENCEWITH LIFE-STYLE AND ENVIRONMENT, Ophthalmology, 102(3), 1995, pp. 475-482

Authors: ROSSDEGNAN D SOUMERAI SB FORTESS E GURWITZ JH
Citation: D. Rossdegnan et al., EXAMINING PRODUCT RISK IN CONTEXT - THE CASE OF ZOMEPIRAC - REPLY, JAMA, the journal of the American Medical Association, 272(16), 1994, pp. 1252-1252

Authors: ROSSDEGNAN D SOUMERAI SB FORTESS EE GURWITZ JH
Citation: D. Rossdegnan et al., WITHDRAWAL OF A DRUG FROM THE MARKET - WHAT SHOULD THE PRESCRIBER DO, JAMA, the journal of the American Medical Association, 272(16), 1994, pp. 1253-1253

Authors: SOUMERAI SB MCLAUGHLIN TJ ROSSDEGNAN D CASTERIS CS BOLLINI P
Citation: Sb. Soumerai et al., EFFECTS OF LIMITING MEDICAID DRUG-REIMBURSEMENT BENEFITS ON THE USE OF PSYCHOTROPIC AGENTS AND ACUTE MENTAL-HEALTH-SERVICES BY PATIENTS WITH SCHIZOPHRENIA, The New England journal of medicine, 331(10), 1994, pp. 650-655

Authors: SOUMERAI SB ROSSDEGNAN D FORTESS EE ABELSON J
Citation: Sb. Soumerai et al., A CRITICAL ANALYSIS OF STUDIES OF STATE DRUG REIMBURSEMENT POLICIES -RESEARCH IN NEED OF DISCIPLINE, The Milbank quarterly, 71(2), 1993, pp. 217-252

Authors: ROSSDEGNAN D
Citation: D. Rossdegnan, BAD MEDICINE - THE PRESCRIPTION DRUG-INDUSTRY IN THE THIRD-WORLD - SILVERMAN,M, LYDECKER,M, LEE,PR, Health affairs, 12(2), 1993, pp. 208-210

Authors: HOGERZEIL HV",BIMO,"ROSSDEGNAN D LAING RO OFORIADJEI D SANTOSO B CHOWDHURY AKA DAS AM KAFLE KK MABADEJE AFB MASSELE AY
Citation: D. Hogerzeil Hv",bimo,"rossdegnan et al., FIELD-TESTS FOR RATIONAL DRUG-USE IN 12 DEVELOPING-COUNTRIES, Lancet, 342(8884), 1993, pp. 1408-1410

Authors: SOUMERAI SB SALEMSCHATZ S AVORN J CASTERIS CS ROSSDEGNAN D POPOVSKY MA
Citation: Sb. Soumerai et al., A CONTROLLED TRIAL OF EDUCATIONAL OUTREACH TO IMPROVE BLOOD-TRANSFUSION PRACTICE, JAMA, the journal of the American Medical Association, 270(8), 1993, pp. 961-966

Authors: ROSSDEGNAN D SOUMERAI SB FORTESS EE GURWITZ JH
Citation: D. Rossdegnan et al., EXAMINING PRODUCT RISK IN CONTEXT - MARKET WITHDRAWAL OF ZOMEPIRAC ASA CASE-STUDY, JAMA, the journal of the American Medical Association, 270(16), 1993, pp. 1937-1942
Risultati: 1-21 |